APA (7th ed.) Citation

Zhang, Y., Wang, Y., Li, G., Zhao, X., Wang, K., Jia, C., . . . Zhang, Y. (2024). A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and older. Vaccine, 42(11), 2858-2866. https://doi.org/10.1016/j.vaccine.2024.03.044

Chicago Style (17th ed.) Citation

Zhang, Yuhui, et al. "A Randomized, Blind, Parallel Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People Aged 2 years and Older." Vaccine 42, no. 11 (2024): 2858-2866. https://doi.org/10.1016/j.vaccine.2024.03.044.

MLA (9th ed.) Citation

Zhang, Yuhui, et al. "A Randomized, Blind, Parallel Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People Aged 2 years and Older." Vaccine, vol. 42, no. 11, 2024, pp. 2858-2866, https://doi.org/10.1016/j.vaccine.2024.03.044.